en · de · es · fr · pt
dihexa-notes.peptides6908.com › Guide › Chemical Identity And Naming — 2026 Update

Chemical Identity And Naming — 2026 Update

By Editorial Desk · published 2026-03-13 · last reviewed 2026-04-08 · Guide

A practical reference on Synthetic peptide: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

Reviewed 2026-04-08. Anything still debated is marked as such rather than presented as settled.

Chemical Identity and Naming

The angiotensin IV connection places dihexa in a family of short peptides studied for effects on central nervous system signaling. Angiotensin IV itself is a metabolite of angiotensin II, and analogs have been explored in cardiovascular and neurological research. Dihexa differs from the natural peptide through structural modifications intended to alter stability and receptor interactions. Published descriptions sometimes call it a hepatocyte growth factor mimetic, although that label reflects proposed activity rather than a confirmed clinical mechanism.

Identity checks for dihexa usually rely on mass spectrometry and chromatographic purity analysis. A lyophilized powder is the common supplied form, and it may appear as a white to off-white solid. Aqueous solubility is limited, so laboratory work often uses an organic solvent such as dimethyl sulfoxide to prepare stock solutions. Because the peptide is not a standard pharmaceutical product, exact specifications can vary between suppliers. Certificates of analysis may accompany a batch, but they are not equivalent to regulatory approval.

Proposed Mechanism And Evidence Gaps

The leading hypothesis for dihexa centers on hepatocyte growth factor (HGF) and its receptor, c-Met. In cell-based assays, dihexa has been reported to potentiate HGF-dependent signaling. That pathway influences cell growth, survival, and motility. Because c-Met signaling is widespread, the proposed mechanism is broad rather than specific to neurons. The exact binding site and stoichiometry remain areas of active investigation, and independent replication is limited. This uncertainty limits firm conclusions about how the compound acts in living organisms.

Animal studies have examined dihexa in models of cognitive impairment, synaptic plasticity, and memory. Some reports describe improved performance on maze or avoidance tasks after administration. These findings are preclinical and often involve small samples, varied routes, and differing formulations. Results in rodents do not establish effects in humans. The absence of published randomized controlled trials in people is a major gap in the evidence base. Observational reports and user accounts do not substitute for controlled clinical data.

Dihexa at a glance

PropertyValueNotes
Chemical classSynthetic peptide analogModeled on angiotensin IV; not a natural hormone.
Common synonymsDihexa; N-hexanoic-Tyr-Ile-(6)-aminohexanoic amideNaming conventions differ across vendors and papers.
CAS Registry Number1401708-83-6Listed in some chemical databases; verify against primary sources.
AppearanceWhite to off-white powderTypical form for lyophilized research peptides.
SolubilitySoluble in DMSO; limited in waterOrganic stock solutions are common in laboratory settings.

Dihexa Chemical Identity and Origin

The full name often given is N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. This name indicates a chain containing tyrosine, isoleucine, and a six-carbon amino acid derivative. Databases list a CAS Registry Number and a molecular formula for the compound. The peptide is small compared with proteins, and its structure allows it to be studied in cell cultures and animal models. Exact identity depends on the supplier's synthesis and purification process. Minor impurities can remain after synthesis.

Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.

Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.

Related pages on this site

Background And Research Context

Dihexa appears in scientific literature, patent documents, and commercial catalogs under several names, which can complicate searching and verification. The compound is frequently grouped with nootropics or research chemicals, terms that describe context of use rather than regulatory approval. Such labeling may imply benefits that have not been confirmed in controlled human studies. Readers encountering promotional descriptions should distinguish between preclinical observations and established medical facts. The absence of regulatory approval is a central feature of its current status.

Dihexa is a synthetic peptide-like compound studied in preclinical research for its reported effects on synaptic growth and cognitive measures in animal models. It is often described as an analog of angiotensin IV, a naturally occurring peptide fragment. The compound has not been approved as a medicine in any major jurisdiction. Most public information comes from laboratory studies, patents, and online vendor listings rather than from large clinical trials. Its scientific status therefore differs from that of an established pharmaceutical.

Research interest in dihexa centers on its ability to promote synapse formation in cultured neurons and in some rodent experiments. These findings have been interpreted as a possible mechanism for learning and memory effects, but the evidence remains preliminary. Independent replication is limited, and study designs vary widely in species, duration, and outcome measures. Human data are scarce, so claims about cognitive enhancement in people are not supported by robust clinical evidence. The gap between laboratory signals and proven clinical benefit is substantial.

Handling, Storage, and Verification

Identity and purity are usually assessed with reverse-phase high-performance liquid chromatography and mass spectrometry. These methods can separate related impurities and confirm molecular mass, but they do not by themselves establish biological activity. Certificate of analysis documents may report purity as a percentage by area, yet the exact meaning can vary between laboratories. Independent testing can check for residual solvents, counterions, or microbial contamination when relevant. For research use, matching analytical records to a specific lot helps trace experimental variability.

Dihexa occupies an uncertain regulatory space in many countries. It is not generally listed as an approved therapeutic, and some jurisdictions may treat it as a research chemical, a compounded substance, or an unapproved new drug depending on claims and distribution. Importation can be restricted, and suppliers may require documentation that the material is for laboratory research only. Quality and labeling vary, so buyers should request analytical data, verify lot numbers, and understand local rules. These factors make sourcing and compliance part of the practical context around dihexa.

Notes from published material

== Field rations == Field rations, called manot krav, usually consist of canned tuna, sardines, beans, stuffed vine leaves, maize and fruit cocktail and bars of halva. Packets of fruit flavored drink powder are provided along with condiments like ketchup, mustard, chocolate spread and jam. Around 2010, the IDF announced that certain freeze dried MREs served in water-activated disposable heaters like goulash, turkey schwarma and meatballs would be introduced as field rations. One staple of these rations was loof, a type of Kosher spam made from chicken or beef that was phased out around 2008. Food historian Gil Marks has written that: "Many Israeli soldiers insist that Loof uses all the parts of the cow that the hot dog manufacturers will not accept, but no one outside of the manufacturer and the kosher supervisors actually know what is inside."

=== Military uses === Acrolein was used in warfare due to its irritant and blistering properties. The French used the chemical in their hand grenades and artillery shells during World War I under the name "Papite".

Amat-Mamu was a nadītu, a priestess to the god Shamash. She was the daughter of Sin-ilum (also transcribed as Sîn-ilum or Sin-ili). Sin-ilum was the son of Sin-tajjār, who in turn was the son of Akšāja. Amat-Mamu had a cousin, an aunt, and a great aunt who were all nadītus as well. Nadītus were sometimes allowed to choose their own heirs, including potential heirs outside of their own families. Such an option was allowed to the nadītu Belessunu, daughter of Mannium, as part of the terms of her own adoption as the heir of her aunt Naramtum, and Belessunu adopted Amat-Mamu as her heir. Amat-Mamu inherited four fields totaling 46 acres: a five-acre field and a 20 acre field in the Pzur-Ilaba district, a nine-acre field in the Akbarum district, and a 12 acre field in the Pahuşu district. She also inherited two plots of land: one and one-third sar of partially developed land in the cloister and six sar of undeveloped land of Sippar-rabum. Amat-Mamu inherited three slaves from Belessunu: Ana-pani-Šamaš-nadi, Sin-mašmaš, and Sin-mašmaš's brother. Also inherited were a house, two copper pots, and two axes. Amat-Mamu was given the deeds, or "mother tablets", entitling her to Belessunu's property. Per the terms of the agreement, Amat-Mamu was required to pay Belessunu's debts and provide for her while she lived. The debt totaled two-thirds mina, six shekels of silver. To provide for Belessunu, Amat-Mamu was required to provide Belessunu with six gurs of grain, 12 minas of wool, 24 liters of oil, six feasts, 20 liters of flour, and two pieces of meat each year.

Sources: en.wikipedia.org

Further detail

== Variations == In addition to performing the reaction in a variety of organic solvents, conditions have been devised which allow for a broad range of Stille couplings in aqueous solvent. In the presence of Cu(I) salts, palladium-on-carbon has been shown to be an effective catalyst. In the realm of green chemistry a Stille reaction is reported taking place in a low melting and highly polar mixture of a sugar such as mannitol, a urea such as dimethylurea and a salt such as ammonium chloride. The catalyst system is tris(dibenzylideneacetone)dipalladium(0) with triphenylarsine:

=== Fluorine === 18F decays predominantly by β emission, with a half-life of 109.8 min. It is made by proton bombardment of 18O in a cyclotron or linear particle accelerator. It is an important isotope in the radiopharmaceutical industry. For example, it is used to make labeled fluorodeoxyglucose (FDG) or D-3-[18F]fluoroalanine for application in PET scans.

== References == Osada, Y., Nakagawa, T., Membrane Science and Technology, New York: Marcel Dekker, Inc,1992. Zeman, Leos J., Zydney, Andrew L., Microfiltration and Ultrafitration, Principles and Applications., New York: Marcel Dekker, Inc,1996. Mulder M., Basic Principles of Membrane Technology, Kluwer Academic Publishers, Netherlands, 1996. Jornitz, Maik W., Sterile Filtration, Springer, Germany, 2006 Van Reis R., Zydney A. Bioprocess membrane technology. J Mem Sci. 297(2007): 16-50. Templin T., Johnston D., Singh V., Tumbleson M.E., Belyea R.L. Rausch K.D. Membrane separation of solids from corn processing streams. Biores Tech. 97(2006): 1536-1545. Ripperger S., Schulz G. Microporous membranes in biotechnical applications. Bioprocess Eng. 1(1986): 43-49. Thomas Melin, Robert Rautenbach, Membranverfahren, Springer, Germany, 2007, ISBN 3-540-00071-2. Munir Cheryan, Handbuch Ultrafiltration, Behr, 1990, ISBN 3-925673-87-3. Eberhard Staude, Membranen und Membranprozesse, VCH, 1992, ISBN 3-527-28041-3.

Most metabolic processes have a specific and narrow range of pH where operation is possible, multiple regulatory systems are in place to maintain homeostasis. Fluctuations away from optimal operating pH can slow or impair reactions and possibly cause damage to cellular structures or proteins. To maintain homeostasis the body may excrete excess acid or base through the urine, via gas exchange in the lungs, or buffer it in the blood. The bicarbonate buffering system of blood plasma effectively holds a steady pH and helps to hold extracellular pH around 7.35. The kidneys are responsible for the majority of acid-base regulation but can excrete urine no lower than a pH of 5. This means that a 330mL can of cola, for example, usually ranging in pH from 2.8 to 3.2, would need to be diluted 100 fold before being excreted. Instead of producing 33L of urine from one can of cola, the body relies on buffer to neutralize the acid. Systemic acidosis can be the result of multiple factors, not just diet. Anaerobic exercise, diabetes, AIDS, aging, menopause, inflammation, infections, tumours, and other wounds and fractures all contribute to acidosis. Blood has an average pH of 7.40 but interstitial fluid can vary. Interstitial pH of the skin, for example, is ~7.1. There is no data available for bone.

Sources: en.wikipedia.org

Background from the literature

The effects of growth hormone (GH) deficiency vary depending on the age at which they occur. Alterations in somatomedin can result in growth hormone deficiency with two known mechanisms; failure of tissues to respond to somatomedin, or failure of the liver to produce somatomedin. Major manifestations of GH deficiency in children are growth failure, the development of a short stature, and delayed sexual maturity. In adults, somatomedin alteration contributes to increased osteoclast activity, resulting in weaker bones that are more prone to pathologic fracture and osteoporosis. However, deficiency is rare in adults, with the most common cause being a pituitary adenoma. Other adult causes include a continuation of a childhood problem, other structural lesions or trauma, and very rarely idiopathic GHD. Adults with GHD "tend to have a relative increase in fat mass and a relative decrease in muscle mass and, in many instances, decreased energy and quality of life". Diagnosis of GH deficiency involves a multiple-step diagnostic process, usually culminating in GH stimulation tests to see if the patient's pituitary gland will release a pulse of GH when provoked by various stimuli.

== Efficacy == There is no clear measure of the effectiveness of the war on drugs, and it has been widely called a policy failure. Thirty years into the campaign, a National Research Council report, "Informing America's Policy on Illegal Drugs" (2001), found that "existing drug-use monitoring systems are strikingly inadequate to support the full range of policy decisions that the nation must make." The report noted that studies of efforts to address drug usage and smuggling, from US military operations to eradicate coca fields in Colombia, to domestic drug treatment centers, had all been inconclusive, if the programs had been evaluated at all: It concluded, "It is unconscionable for this country to continue to carry out a public policy of this magnitude and cost without any way of knowing whether and to what extent it is having the desired effect." Writing in the New Statesmen in 2021, journalist James Bloodworth stated, "The war on drugs is a failure. We know this. We've long known it. In fact, there is such an abundance of evidence for its failure that we have more certainty here than in most areas of policy. ... According to the International Drug Policy Consortium there was a 31 per cent global increase in drug taking between 2011 and 2016. ...

The first scientists to determine relative atomic masses were John Dalton and Thomas Thomson between 1803 and 1805 and Jöns Jakob Berzelius between 1808 and 1826. Relative atomic mass (Atomic weight) was originally defined relative to that of the lightest element, hydrogen, which was taken as 1.00, and in the 1820s, Prout's hypothesis stated that atomic masses of all elements would prove to be exact multiples of that of hydrogen. Berzelius, however, soon proved that this was not even approximately true, and for some elements, such as chlorine, relative atomic mass, at about 35.5, falls almost exactly halfway between two integral multiples of that of hydrogen. Still later, this was shown to be largely due to a mix of isotopes, and that the atomic masses of pure isotopes, or nuclides, are multiples of the hydrogen mass, to within about 1%. In the 1860s, Stanislao Cannizzaro refined relative atomic masses by applying Avogadro's law (notably at the Karlsruhe Congress of 1860). He formulated a law to determine relative atomic masses of elements: the different quantities of the same element contained in different molecules are all whole multiples of the atomic weight and determined relative atomic masses and molecular masses by comparing the vapor density of a collection of gases with molecules containing one or more of the chemical element in question. In the 20th century, until the 1960s, chemists and physicists used two different atomic-mass scales.

Flareups continued to occur starting on June 19, sending more smoke into the air which continued to impact the local Boyle Heights community. The warehouse also experienced severe structural damage during the fire. The solar panels on the roof and the collapse of roof structure made fighting the fire difficult. On June 18, the shelter-in-place order was briefly reinstated after crews detected hydrogen fluoride, indicating that a lithium-ion battery (likely from a battery-operated forklift) had ignited inside the facility. Officials also raised concerns that the estimated 85 million pounds of frozen food (including bread, poultry, pork, and beef) inside the facility—no longer kept cold by the damaged refrigeration system—would begin to decompose, creating foul odors and potential biohazards, which Mayor Bass compared to food spoiling during a prolonged power outage. Health concerns intensified as the fire continued, with officials extending particulate matter advisories and Los Angeles Unified School District relocating students from several nearby schools due to air quality impacts. Regulatory monitors and sensors recorded improved PM2.5 levels in Central and Southeast Los Angeles, the San Gabriel Valley, and the San Fernando Valley, though air quality near the fire itself remained elevated, with "Very Unhealthy" conditions measured throughout the day in Boyle Heights; other areas ranged from "Good" to "Moderate" for PM2.5.

=== Research === A major source of bubble instability is when a wide variety of sizes of bubbles are created, gases in smaller bubbles diffuses or disperses into larger bubbles. This is due to their differing Laplace pressures. As of 2023, technologies to control bubble size, distribution and movement were difficult to employ during production. "Advanced" research was underway, including by companies such as Nestlé. In 2013, scientists released the results of experimental research on the impact of phospholipids on aerating cocoa butter. The research found that although all phospholipids tested made cocoa butter foam more, the foam's stability varied by type of phospholipid. The final cocoa butter was also observed to be more stable when the process was undertaken at lower temperatures.

Sources: en.wikipedia.org

Frequently asked questions

What is dihexa?

Dihexa is a synthetic peptide analog related to angiotensin IV. It is studied in preclinical research for effects on neural signaling and synapse formation. It is not an approved medicine.

Is dihexa the same as angiotensin IV?

No. Dihexa shares a conceptual link to angiotensin IV but has different structural features. Those changes are intended to modify its behavior in biological systems.

How is dihexa named in chemical databases?

It often appears as N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. Synonyms and CAS listings vary, so cross-checking identifiers is necessary.

What is the proposed mechanism of dihexa?

It is thought to enhance hepatocyte growth factor signaling through the c-Met receptor. This pathway is involved in cell growth and repair. The precise molecular details are not fully established.

Network